Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Metastasis02:30

Metastasis

6.3K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K
Tumor Progression02:07

Tumor Progression

7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Astrocyte heterogeneity in brain metastases.

Molecular oncology·2026
Same author

Patient-derived resources for decoding and targeting brain metastases ecosystems.

EMBO molecular medicine·2026
Same author

GPNMB-directed CAR T cell therapy against MiT/TFE-family fusion-driven solid tumors.

Nature cancer·2026
Same author

Covalent pan-TEAD inhibitors block YAP activity and demonstrate brain penetrance in a Hippo-dependent cancer model.

Nature communications·2026
Same author

Combining the KRAS<sup>G12C</sup> inhibitor adagrasib with anti-PD-1 immunotherapy improves overall survival and prevents recurrence in preclinical models of brain metastasis.

Neuro-oncology advances·2026
Same author

Extracellular Vesicles in the Biology and Liquid Biopsy Diagnostics of Pediatric High-Grade Glioma - Emerging Findings and Opportunities.

Journal of extracellular biology·2026

Related Experiment Video

Updated: Jan 2, 2026

Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging
06:44

Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging

Published on: June 7, 2020

7.9K

Brain metastasis.

Adrienne Boire1, Priscilla K Brastianos2, Livia Garzia3

  • 1Memorial Sloan Kettering Cancer Center, New York, NY, USA. boirea@mskcc.org.

Nature Reviews. Cancer
|November 30, 2019
PubMed
Summary

Brain metastasis in lung cancer, breast cancer, and melanoma presents significant challenges. Developing better preclinical models is crucial for understanding brain metastasis and improving patient outcomes.

More Related Videos

Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis
07:43

Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis

Published on: February 8, 2017

28.0K
Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread
05:23

Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread

Published on: July 7, 2023

1.5K

Related Experiment Videos

Last Updated: Jan 2, 2026

Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging
06:44

Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging

Published on: June 7, 2020

7.9K
Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis
07:43

Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis

Published on: February 8, 2017

28.0K
Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread
05:23

Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread

Published on: July 7, 2023

1.5K

Area of Science:

  • Oncology
  • Neuroscience
  • Cancer Biology

Background:

  • Brain metastasis is a frequent complication of primary cancers like lung, breast, and melanoma, leading to poor prognoses.
  • The unique brain microenvironment imposes selective pressures that influence tumor cell behavior and treatment resistance.
  • Understanding these unique challenges is critical for developing effective therapies.

Purpose of the Study:

  • To highlight the distinct biological and clinical challenges posed by brain metastasis.
  • To emphasize the need for improved preclinical models that accurately recapitulate the brain metastatic process.
  • To gather expert opinions on advancing brain metastasis research and management.

Main Methods:

  • This viewpoint synthesizes the opinions of four leading experts in the field of brain metastasis.
  • The discussion focuses on the biology, microenvironment, and therapeutic strategies related to brain metastasis.
  • Expert insights address the limitations of current research models.

Main Results:

  • The brain microenvironment significantly shapes tumor cell adaptation and therapeutic responses, differing from extracranial sites.
  • A critical lack of robust preclinical models hinders comprehensive investigation of brain metastasis.
  • Improved models are essential for uncovering new therapeutic targets and strategies.

Conclusions:

  • Addressing the unmet clinical need in brain metastasis requires a deeper understanding of its unique biology.
  • Developing and utilizing advanced preclinical models is paramount for future research and clinical advancements.
  • Insights gained could also benefit the study of primary brain tumors.